Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protra...

por Yamada, Y, Hamaguchi, T, Goto, M, Muro, K, Matsumura, Y, Shimada, Y, Shirao, K, Nagayama, S
Publicado 2003

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer

por Yamada, Y, Tahara, M, Miya, T, Satoh, T, Shirao, K, Shimada, Y, Ohtsu, A, Sasaki, Y, Tanigawara, Y
Publicado 2008

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

por Koizumi, W, Tanabe, S, Saigenji, K, Ohtsu, A, Boku, N, Nagashima, F, Shirao, K, Matsumura, Y, Gotoh, M
Publicado 2003

Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus.

por Natsugoe, S., Mueller, J., Kijima, F., Aridome, K., Shimada, M., Shirao, K., Kusano, C., Baba, M., Yoshinaka, H., Fukumoto, T., Aikou, T.
Publicado 1997

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

por Matsumura, Y, Hamaguchi, T, Ura, T, Muro, K, Yamada, Y, Shimada, Y, Shirao, K, Okusaka, T, Ueno, H, Ikeda, M, Watanabe, N
Publicado 2004

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastr...

por Matsubara, J, Nishina, T, Yamada, Y, Moriwaki, T, Shimoda, T, Kajiwara, T, Nakajima, T E, Kato, K, Hamaguchi, T, Shimada, Y, Okayama, Y, Oka, T, Shirao, K
Publicado 2008

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

por Hamaguchi, T, Kato, K, Yasui, H, Morizane, C, Ikeda, M, Ueno, H, Muro, K, Yamada, Y, Okusaka, T, Shirao, K, Shimada, Y, Nakahama, H, Matsumura, Y
Publicado 2007